CXCL13 is implicated in the trafficking of B-cells into tissues and has been shown to be upregulated in NPC biopsies, as has CD40 [7], also found upregulated in the transgenic samples. The gene discussed is CXCL13; the disease is nasopharyngeal carcinoma.